Overview

Comparison of Two Strategies of Glucocorticoid Withdrawal in Rheumatoid Arthritis Patients

Status:
Recruiting
Trial end date:
2022-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the proportion of patients who could withdraw from prednisone and hydrocortisone one year after a progressive decrease of GC (GC tapering) or a hydrocortisone replacement therapy in rheumatoid arthritis in remission or low disease activity.
Phase:
Phase 4
Details
Lead Sponsor:
University Hospital, Toulouse
Treatments:
Cortisol succinate
Glucocorticoids
Hydrocortisone
Hydrocortisone 17-butyrate 21-propionate
Hydrocortisone acetate
Prednisone